The AI model, published on March 17, 2026, provides insights into how chemicals can influence gene expression, which is critical for drug discovery.
By understanding these interactions, the model aims to identify potential treatments that can restore normal gene regulation in diseased cells.
This advancement could lead to reduced timeframes and costs associated with drug development, enhancing the efficiency of bringing new therapies to market.